Mainz Biomed B.V. (MYNZ): Price and Financial Metrics

Mainz Biomed B.V. (MYNZ): $1.43

0.10 (-6.54%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

MYNZ Price/Volume Stats

Current price $1.43 52-week high $23.20
Prev. close $1.53 52-week low $1.42
Day low $1.42 Volume 60,700
Day high $1.53 Avg. volume 193,833
50-day MA $2.51 Dividend yield N/A
200-day MA $6.25 Market Cap 4.92M

MYNZ Stock Price Chart Interactive Chart >


Mainz Biomed B.V. (MYNZ) Company Bio


Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.


MYNZ Latest News Stream


Event/Time News Detail
Loading, please wait...

MYNZ Latest Social Stream


Loading social stream, please wait...

View Full MYNZ Social Stream

MYNZ Price Returns

1-mo -31.90%
3-mo -66.35%
6-mo N/A
1-year -92.04%
3-year -99.65%
5-year N/A
YTD -66.90%
2024 -90.69%
2023 -83.66%
2022 -31.67%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!